Cancer News and Research

Latest Cancer News and Research

Intermediate size nanoparticles may be effective at stopping internal bleeding

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide.

17 Feb 2022

Research shows alterations in transfer RNAs at the epigenetic level in cancer

A recently published paper in the journal Molecular Cancer by the group of Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, ICREA Research Professor and Genetics Chairman at the University of Barcelona, shows that transfer RNAs for certain amino acids are altered at the epigenetic level in some types of cancer, expressing it in an exaggerated manner in some cases and being deficient in others.

17 Feb 2022

New finding may aid in development of vaccines against future animal-to-human viral diseases

A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans - including SARS-CoV-2, the cause of COVID-19 - may be possible, say Johns Hopkins Medicine researchers, based on findings from their recent study.

17 Feb 2022

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

A new mutation was identified in 9 percent of relapsed cases of pediatric acute myeloid leukemia (AML) that may define a new subtype of the disease.

17 Feb 2022

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published Feb. 17, 2022, in JAMA Oncology.

17 Feb 2022

New METPlatform allows researchers to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

17 Feb 2022

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Treating a tumor in the breast when distant metastases have already occurred does not improve outcomes in women with stage IV breast cancer, according to a new study published in the Journal of Clinical Oncology.

17 Feb 2022

New NYU Langone Ambulatory Care Center East 53rd Street offers gynecologic, obstetric, and wellness care

As part of its commitment to enhance access to high-quality care, NYU Langone Health has begun the phased opening of NYU Langone Ambulatory Care Center East 53rd Street, at 159 East 53rd Street, offering comprehensive gynecologic, obstetric, and wellness care.

17 Feb 2022

Penn State researchers receive $3.9 million to study the impact of COVID-19 on pregnancy

The Pennsylvania Department of Health has awarded Penn State College of Medicine $3.9 million through May 2025 to study the impact COVID-19 has on pregnancy.

17 Feb 2022

New high-risk subtype of relapsed pediatric AML revealed

When acute myeloid leukemia (AML) relapses, it is more difficult to treat and outcomes are dismal. Scientists at St. Jude Children's Research Hospital have discovered a mutation in pediatric AML that physicians can use to identify high-risk patients and better guide treatment.

17 Feb 2022

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Optical genome mapping involves the extraction of very long DNA molecules, for example routinely collected blood samples or bone marrow material from patients.

17 Feb 2022

Combating leukemia cells by disrupting their energy maintenance mechanism

Acute myeloid leukemia, which affects blood and bone marrow cells, is a particularly dangerous form of cancer. More than half of patients under the age of 60 die.

17 Feb 2022

Identifying direct and indirect effects of SARS-CoV-2 pandemic on mortality in the US

Researchers recently differentiated the direct and indirect impacts of the SARS-CoV-2 pandemic on mortality in the United States.

17 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

From Illumina, Inc. 17 Feb 2022

New Olympus Discovery Center opens to advance human disease research

Olympus is proud to announce the opening of the Olympus Discovery Center at Texas A&M Health to support research focused on treating, alleviating and preventing human diseases.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Study shows how some cancer cells immobilize T cells

Our immune systems have the potential to find and destroy cancer cells. But cancer cells can be clever and develop tricks to evade the immune system.

16 Feb 2022

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

Gene therapy trials for sickle cell disease have been showing great promise, even offering hope of a cure. But in early 2021, the trials ground to a halt after reports of blood malignancies in two people in a trial sponsored by bluebird bio.

16 Feb 2022

UVMCC researchers address new paradigms in rectal cancer multidisciplinary care

In recent years total neoadjuvant treatment (TNT) - a potent new treatment approach for advanced colorectal cancer that confronts tumors with aggressive rounds of chemotherapy and chemoradiation followed by surgery to remove the cancerous tissue - has emerged as the standard of care.

16 Feb 2022

Global human microbiome research dominated by highly developed countries

New studies emerge daily on the effect of the human microbiome on human health: colon cancer, ulcers, and cognitive conditions such as Alzheimer's disease have been associated with the communities of microbes that live in our bodies.

16 Feb 2022

Cancer News and Research

Latest Cancer News and Research

Intermediate size nanoparticles may be effective at stopping internal bleeding

Research shows alterations in transfer RNAs at the epigenetic level in cancer

New finding may aid in development of vaccines against future animal-to-human viral diseases

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

New METPlatform allows researchers to test drugs for possible use in brain metastases

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

New NYU Langone Ambulatory Care Center East 53rd Street offers gynecologic, obstetric, and wellness care

Penn State researchers receive $3.9 million to study the impact of COVID-19 on pregnancy

New high-risk subtype of relapsed pediatric AML revealed

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Combating leukemia cells by disrupting their energy maintenance mechanism

Identifying direct and indirect effects of SARS-CoV-2 pandemic on mortality in the US

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

New Olympus Discovery Center opens to advance human disease research

Smartphone-based COVID-19 detection system

Study shows how some cancer cells immobilize T cells

Study investigates what causes blood malignancies linked to gene therapy for sickle cell disease

UVMCC researchers address new paradigms in rectal cancer multidisciplinary care

Global human microbiome research dominated by highly developed countries

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in